Report Categories
View AllRecent Articles
View All
The opportunity most miss about Kymera Therapeutics KYMR Slight Dip 20260508
The technology investments behind Xencor XNCR growth Q4 2025 Profit Surprises
ASRV AmeriServ releases first quarter 2026 earnings results shares post modest gains during todays regular trading session
TCRT Alaunos Therapeutics posts wider Q4 2023 loss than analyst estimates with shares slipping 039 percent in todays trading
External Links
SPG Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results
FRO Q4 2025 Earnings EPS Misses Estimates Shares Edge Lower
CHT Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment
Wordle 1798 Hints Continue to Draw Audience Interest Implications for Digital Puzzle Engagement
AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives 3761 EPS Surprise
PennyMac Mortgage Investment Trust PMTU Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds
Norfolk Southern NSC Q1 2026 Earnings Earnings Beat Amid Flat Revenue Stock Edges Lower